Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Change in Account Payables (2016 - 2026)

Ani Pharmaceuticals' Change in Account Payables history spans 14 years, with the latest figure at -$7.2 million for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 6.07% to -$7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.2 million, a 3064.09% increase, with the full-year FY2025 number at $15.2 million, up 3064.09% from a year prior.
  • Change in Account Payables hit -$7.2 million in Q4 2025 for Ani Pharmaceuticals, down from $13.8 million in the prior quarter.
  • Over the last five years, Change in Account Payables for ANIP hit a ceiling of $13.8 million in Q3 2025 and a floor of -$9.1 million in Q3 2022.
  • Historically, Change in Account Payables has averaged $1.9 million across 5 years, with a median of $2.6 million in 2021.
  • The widest YoY moves for Change in Account Payables: up 753.23% in 2022, down 602.32% in 2022.
  • Tracing ANIP's Change in Account Payables over 5 years: stood at $9.8 million in 2021, then rose by 3.02% to $10.1 million in 2022, then plummeted by 72.38% to $2.8 million in 2023, then tumbled by 345.36% to -$6.8 million in 2024, then decreased by 6.07% to -$7.2 million in 2025.
  • Business Quant data shows Change in Account Payables for ANIP at -$7.2 million in Q4 2025, $13.8 million in Q3 2025, and $3.1 million in Q2 2025.